White Marvin L 4
4 · Aptevo Therapeutics Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
White Marvin L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-03-02+12,917→ 57,846 total - Exercise/Conversion
Common Stock
2024-03-03+9,584→ 67,430 total - Exercise/Conversion
Restricted Stock Unit
2024-03-02−12,917→ 25,833 total→ Common Stock (12,917 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-03−9,584→ 9,584 total→ Common Stock (9,584 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 3, 2023, the reporting person was granted 38,750 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
- [F3]On June 7, 2022, the reporting person was granted 28,750 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.